20xx年醫(yī)學(xué)專題—三年來藥品不良反應(yīng)數(shù)據(jù)的統(tǒng)計(jì)與分析-展示頁(yè)
2024-11-19 04:32本頁(yè)面
【正文】 合計(jì)1%59%99%。有吸煙史、飲酒史或者二者兼有25例，%。： 159例不良反響報(bào)告中，有既往藥品不良反響1例，%；無既往藥品不良反響75例，%；既往藥品不良反響情況不詳83例，%。漢族147例，%；回族1例，%；布依族1例，%；情況不明10例，%。:、年令和民族分布情況： 159例不良反響報(bào)告中，男80例，女79例，男:女=1:1。其中一例不良反響為皮疹加重，一例為皮疹發(fā)熱，一例為腹瀉。其中生產(chǎn)企業(yè)上報(bào)2例，%；經(jīng)營(yíng)企業(yè)上報(bào)88例，%；醫(yī)療機(jī)構(gòu)上報(bào)66例，%；個(gè)人上報(bào)3例，%〔詳見表3〕。：159例不良反響報(bào)告均為首次報(bào)告，其中2022年46例，%；2021年53例 ，%；2021年60例，%〔詳見表1〕。：采用國(guó)家藥品不良反響監(jiān)測(cè)系統(tǒng)〔版本CDR 〕標(biāo)準(zhǔn)術(shù)語，藥品名稱采用藥品注冊(cè)批件中通用名稱。根據(jù)有關(guān)規(guī)定，剔除了非本公司產(chǎn)品的不良反響報(bào)告病例。1. 資料與方法 ： 國(guó)家藥品不良反響監(jiān)測(cè)系統(tǒng)反響的2022年、2021年、2021年陜西君碧莎制藥不良反響報(bào)告作為研究數(shù)據(jù)庫(kù)。 feedback data。 in the suspected drug, BAIXIAN xiatare tablet 57 cases, 25 cases of skin blood poison tablets, promote menstruation pregnancy pill in 14 cases. Conclusion the establishment of the national adverse drug reaction monitoring system has played an important role in ensuring the safety of drug use and improving the evaluation of drug products. The incidence rate of adverse reactions in our pany is less than %,Very rare, high product safety.Keywords： adverse drug reaction。關(guān)鍵詞 藥品不良反響；監(jiān)測(cè)系統(tǒng)；反響數(shù)據(jù)；分析評(píng)價(jià)Analysis and evaluation of feedback data in 159 cases of adverse drug reaction monitoring systemLi Lieqiao (Shaanxi junbisha Pharmaceutical Co. Ltd. Xianyang 721000)Abstract objective to collect Shaanxi junbisha Pharmaceutical Co., Ltd. in 2022 to 2021 adverse drug reaction (ADR) national drug adverse reactions monitoring system monitoring report of 159 cases, analyzing the monitoring data, in order to provide the reference for the clinical rational drug use. Methods Retrospective study and descriptive statistical methods were used in the data processing of puter. Results of 159 cases of ADR reports involving the system ranking followed by digestive system damage (), systemic damage (%), skin and its appendages (%) and reproductive system damage (%), higher frequency of ADR followed by abdominal pain, diarrhea (54 cases), nausea and vomiting (22 cases), skin rash, itching (22 cases), dizziness (10 cases)。結(jié)果
電大資料相關(guān)推薦
鄂ICP備17016276號(hào)-1